DAX24.863 ±0,0%Est505.976 -0,6%MSCI World4.343 -0,1%Top 10 Crypto8,6500 +2,7%Nas22.541 -0,3%Bitcoin57.445 +3,0%Euro1,1866 ±-0,0%Öl67,53 ±-0,0%Gold5.003 +1,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Siemens 723610 Deutsche Telekom 555750 Siemens Energy ENER6Y Rheinmetall 703000 SAP 716460 Amazon 906866 NVIDIA 918422 Mercedes-Benz Group (ex Daimler) 710000 Lufthansa 823212 BASF BASF11 Microsoft 870747 Heidelberg Materials 604700 Deutsche Bank 514000 DroneShield A2DMAA Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach US-Inflationsdaten: DAX stabil -- Wall Street im Minus -- Amazon im Bärenmarkt -- Delivery Hero, pbb, Siemens, RWE, Rivian, Applied Materials, Adyen, Apple, Arista im Fokus
Top News
Procore Technologies: Jefferies sieht nach der Präsentation des Quartalsberichts 81 % Kurspotenzial! Procore Technologies: Jefferies sieht nach der Präsentation des Quartalsberichts 81 % Kurspotenzial!
NASDAQ Composite Index-Papier Starbucks-Aktie: So viel Verlust wäre bei einem Investment in Starbucks von vor 3 Jahren angefallen NASDAQ Composite Index-Papier Starbucks-Aktie: So viel Verlust wäre bei einem Investment in Starbucks von vor 3 Jahren angefallen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Insmed Aktie

Kaufen
Verkaufen
Insmed Aktien-Sparplan
126,00 EUR +3,00 EUR +2,44 %
STU
150,91 USD +4,77 USD +3,26 %
BTT
Insmed jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.26,69 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1JJA3

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS4576693075

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolINSM

Insmed Aktien News

DatumMeistgelesen
PR NewswireInsmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference
PR NewswireInsmed To Present at December 2024 Investor Conferences
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at November 2024 Investor Conferences
PR NewswireInsmed Reports Third-Quarter 2024 Financial Results and Provides Business Update
PR NewswireInsmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List
PR NewswireInsmed Unites Across Communities Around the World During Third Annual Global Day of Good
PR NewswireInsmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024
PR NewswireNew Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Reports Second-Quarter 2024 Financial Results and Provides Business Update
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireAdditional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference
PR NewswireInsmed to Host Commercial Webinar on June 4, 2024
PR NewswireInsmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
PR NewswireInsmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
PR NewswireInsmed to Host Investor Call to Discuss Topline Results from Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis
PR NewswireInsmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused b...
PR NewswireInsmed Reports First-Quarter 2024 Financial Results and Provides Business Update
PR NewswireInsmed To Present at the BofA Securities Health Care Conference 2024
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at Three March Conferences
PR NewswireInsmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
PR NewswireInsmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at the Nasdaq 49th Investor Conference
PR NewswireInsmed To Present at Two November Conferences

Insmed News

Insmed News: auf dieser Seite finden Sie alle Insmed News und Nachrichten zur Insmed Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Insmed News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Insmed News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.